Implantica reported a mixed financial performance for Q4 2024, with a 30% year-over-year decrease in quarterly revenue to €442,000, while full-year net sales rose by 38% to €1.9 million. The company's ...

Crystal Amber (CRS) is the best performing UK small-cap closed-end fund over the past 12 months and three years, delivering a 35.2 per cent and 75.6 per cent total return, respectively, according to ...